Phase 2 study of BK1304 in healthy childre
Phase 2
- Conditions
- Prevention of influenza
- Registration Number
- JPRN-jRCT2031200156
- Lead Sponsor
- Fuji Hideyuki
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
A person who has written informed consent from legal guardian and has obtained an ascent from subject
Exclusion Criteria
History of influenza virus infection or influenza vaccination within 180 days prior to the first dose of study drug
History of anaphylaxis to food or drug
Judged ineligible for the study by investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method